Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

‘Significant Uncertainty’ Surrounds Dell-EMC Deal

A Wells Fargo analyst cuts his rating on EMC citing potential hurdles to its proposed acquisition by Dell.

Justin Sullivan / Getty

There are a lot of moving and complex parts to Dell’s $67 billion proposal to acquire the data storage company EMC — so many that analyst Maynard Um of Wells Fargo wonders if the deal will ever get closed at all.

In a note to clients today, Um downgraded shares of EMC to “market perform” from “outperform” and lowered his target price range on its shares. “The complexity of this deal and the measurement of the outcomes makes this event challenging and we fear disruption, in the interim, could have an adverse impact on business,” he writes.

Um cited Re/code’s report from Tuesday concerning the potential that a tax bill of as much as $9 billion could complicate or even derail the deal as adding a new wrinkle of uncertainty to the deal.

But Um’s biggest question concerns how to value the tracking stock that Dell has proposed to issue in order to help finance the deal. Dell has proposed to give EMC shareholders tracking shares linked to VMware in addition to cash in order to buy them out.

Um writes that he’s had a “significant challenge” in figuring out how to value the proposed tracking shares. “We find it difficult to come to a definitive value for the tracking stock, and thus struggle to value this as the best proposed deal for shareholders,” he writes. “Until there is better clarity to the value of the tracking stock and/or deal closing, we believe it prudent to lower our rating” on EMC.

Dell, a privately held company, last month proposed to acquire EMC and its stake in VMware in what has amounted to the largest tech M&A deal ever. Dell has proposed giving EMC shareholders 0.111 shares of new tracking stock linked to EMC’s software subsidiary VMware in addition to cash in order to help pay for the massive purchase. The cash would come from about $40 billion in new debt. EMC owns 81 percent of VMware while 19 percent of its equity trades on the New York Stock Exchange. VMware shares have declined by about 25 percent in the month since the deal was announced.

Um lowered his price target on EMC shares to a range of $25 to $28 a share from $29 to $30 a share previously. EMC shares rose more than 1 percent to $25.55 by midday; VMware shares fell 2 percent to $59.27.

This article originally appeared on Recode.net.

See More:

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh